Vertex Pharmaceuticals (VRTX) Q2 2026 Earnings

4MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
4.24
4.53
4.82
5.11

Details

Expected EPS
4.242846
Actual EPS
4.47
Surprise EPS
0.23
Surprise Percent
+5.35%

Description

Vertex Pharmaceuticals (VRTX) has reported earnings of 4.47 per share for Q2 2026.

Prediction

0%
Community
Predictions and Polymarket odds are not investment advice, are not guaranteed, and may change. All investments involve risk, including loss of principal.

1 Comments